{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:50:43Z","timestamp":1783561843095,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002647","name":"Sungkyunkwan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.cgh.2021.04.037","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T02:58:11Z","timestamp":1619578691000},"page":"e583-e599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals"],"prefix":"10.1016","volume":"20","author":[{"given":"In Young","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoosoo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunju","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Heon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hocheol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-8646","authenticated-orcid":false,"given":"Seungho","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.04.037_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.04.037_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.04.037_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.037_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.cgh.2021.04.037_bib5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"issue":"11 Suppl 1","key":"10.1016\/j.cgh.2021.04.037_bib6","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1210\/jc.2008-1399","article-title":"Obesity-associated liver disease","volume":"93","author":"Marchesini","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cgh.2021.04.037_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ijo.2010.216","article-title":"Characterizing the profile of obese patients who are metabolically healthy","volume":"35","author":"Primeau","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.cgh.2021.04.037_bib8","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","article-title":"Identification and characterization of metabolically benign obesity in humans","volume":"168","author":"Stefan","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2021.04.037_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2021.04.037_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ajg.2016.178","article-title":"Metabolically Healthy obesity and the development of nonalcoholic fatty liver disease","volume":"111","author":"Chang","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.037_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14184","article-title":"Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease","volume":"39","author":"Kim","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.04.037_bib12","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/oby.22536","article-title":"Association between nonalcoholic fatty liver disease and future deterioration of metabolic health: a cohort study","volume":"27","author":"Hwang","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cgh.2021.04.037_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12020-017-1313-6","article-title":"Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals","volume":"57","author":"Hashimoto","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.cgh.2021.04.037_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.dld.2014.09.020","article-title":"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.04.037_bib15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.04.037_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.04.037_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.cgh.2021.04.037_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.037_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1323","article-title":"Metabolically healthy obesity and development of chronic kidney disease: a cohort study","volume":"164","author":"Chang","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2021.04.037_bib20","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.037_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.04.037_bib22","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/oby.21358","article-title":"Is 5% weight loss a satisfactory criterion to define clinically significant weight loss?","volume":"23","author":"Williamson","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.cgh.2021.04.037_bib23","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/sim.1203","article-title":"Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects","volume":"21","author":"Royston","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2021.04.037_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ijo.2009.286","article-title":"Gluteofemoral body fat as a determinant of metabolic health","volume":"34","author":"Manolopoulos","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.cgh.2021.04.037_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.04.037_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.04.037_bib27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/gut.2010.214577","article-title":"Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression","volume":"59","author":"Moschen","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.04.037_bib28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in\u00a0nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.04.037_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2009.06.016","article-title":"Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression","volume":"51","author":"Moschen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.04.037_bib30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.04.037_bib31","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.2174\/138161210791208929","article-title":"Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis","volume":"16","author":"Tilg","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.cgh.2021.04.037_bib32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.cgh.2021.04.037_bib33","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.04.037_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.29113","article-title":"Liver fibrosis scores predict liver disease mortality in the United States population","volume":"66","author":"Unalp-Arida","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.04.037_bib35","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/oxfordjournals.aje.a117557","article-title":"Unintentional weight loss in the United States","volume":"142","author":"Meltzer","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cgh.2021.04.037_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1323","article-title":"Metabolically healthy obesity and development of chronic kidney disease: a cohort study","volume":"164","author":"Chang","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2021.04.037_bib37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.14309\/ajg.0000000000000074","article-title":"Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: a cohort study","volume":"114","author":"Chang","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.04.037_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4082\/kjfm.2012.33.3.144","article-title":"Validity and reliability of Korean version of international physical activity questionnaire short form in the elderly","volume":"33","author":"Chun","year":"2012","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.cgh.2021.04.037_bib39","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.cgh.2021.04.037_bib40","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1016\/j.jacc.2014.03.042","article-title":"Metabolically-healthy obesity and coronary artery calcification","volume":"63","author":"Chang","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2021.04.037_bib41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/0301446031000095211","article-title":"Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21\u201382 years","volume":"30","author":"Malavolti","year":"2003","journal-title":"Ann Hum Biol"},{"key":"10.1016\/j.cgh.2021.04.037_bib42","series-title":"Regional Office for the Western Pacific. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment","year":"2000"},{"key":"10.1016\/j.cgh.2021.04.037_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S1368980008002802","article-title":"Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians","volume":"12","author":"Wen","year":"2009","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.cgh.2021.04.037_bib44","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1590-8658(02)80111-6","article-title":"Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild\/moderate abnormalities of liver transaminases","volume":"34","author":"Mathiesen","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.04.037_bib45","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","article-title":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study","volume":"68","author":"Chang","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.04.037_bib46","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.04.037_bib47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521004717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521004717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:37:44Z","timestamp":1761543464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356521004717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1542356521004717"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.04.037","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute","name":"copyright","label":"Copyright"}]}}